Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral minoxidil 1 mg/day versus 2 mg/day for female pattern hair loss
RBR-8sm6kkkPhase 4Completed
- Sponsor
- Clinica Sanabria
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of minoxidil in Female Pattern Hair Loss (FPHL) (2 arms), sponsored by Clinica Sanabria. Started Jun 2024; status: completed.
02
Drugs
minoxidil
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on RBR-8sm6kkk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8sm6kkk.